1-8 of 8
Sonja Zweegman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma

Christie P.M. Verkleij, Chloe A. O’Neill, Marloes E.C. Broekmans, Kristine A. Frerichs, Wassilis S.C. Bruins, Carolien Duetz, Sandy Kruyswijk, Serena R. Baglio, Sheri Skerget, Rocio Montes de Oca, Sonja Zweegman, Raluca I. Verona, Tuna Mutis, Niels W.C.J. van de Donk
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (14): 3006–3022.
https://doi.org/10.1158/1078-0432.CCR-23-3333
Published: 15 July 2024
View article titled, T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma
Open the PDF for T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138

Jort J. van der Schans, Ziyu Wang, Jennemiek van Arkel, Thijs van Schaik, Afroditi Katsarou, Ruud Ruiter, Thomas Baardemans, Huipin Yuan, Joost de Bruijn, Sonja Zweegman, Niels W.C.J. van de Donk, Richard W.J. Groen, Maria Themeli, Tuna Mutis
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (20): 4219–4229.
https://doi.org/10.1158/1078-0432.CCR-23-0132
Published: 13 October 2023
View article titled, Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138
Open the PDF for Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138 in another window
Includes: Supplementary data
Journal Articles

Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis

Lisa C. Holthof, Jort J. van der Schans, Afroditi Katsarou, Renée Poels, Anne T. Gelderloos, Esther Drent, Susan E. van Hal-van Veen, Fengzhi Li, Sonja Zweegman, Niels W.C.J. van de Donk, Maria Themeli, Richard W.J. Groen, Tuna Mutis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3793–3803.
https://doi.org/10.1158/1078-0432.CCR-20-2188
Published: 01 July 2021
View article titled, Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis
Open the PDF for Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis in another window
Includes: Supplementary data
Journal Articles

Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab

Kristine A. Frerichs, Marloes E.C. Broekmans, Jhon A. Marin Soto, Berris van Kessel, Martijn W. Heymans, Lisa C. Holthof, Christie P.M. Verkleij, Rengasamy Boominathan, Bhavesh Vaidya, Jocelyn Sendecki, Amy Axel, Francois Gaudet, Kodandaram Pillarisetti, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W.C.J. van de Donk
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2203–2215.
https://doi.org/10.1158/1078-0432.CCR-19-2299
Published: 01 May 2020
View article titled, Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
Open the PDF for Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab in another window
Includes: Supplementary data
Journal Articles

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

Esther Drent, Renée Poels, Ruud Ruiter, Niels W.C.J. van de Donk, Sonja Zweegman, Huipin Yuan, Joost de Bruijn, Michel Sadelain, Henk M. Lokhorst, Richard W.J. Groen, Tuna Mutis, Maria Themeli
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 4014–4025.
https://doi.org/10.1158/1078-0432.CCR-18-2559
Published: 01 July 2019
View article titled, Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells
Open the PDF for Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells in another window
Includes: Supplementary data
Journal Articles

Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab

Jakub Krejcik, Kris A. Frerichs, Inger S. Nijhof, Berris van Kessel, Jeroen F. van Velzen, Andries C. Bloem, Marloes E.C. Broekmans, Sonja Zweegman, Johan van Meerloo, René J.P. Musters, Pino J. Poddighe, Richard W.J. Groen, Christopher Chiu, Torben Plesner, Henk M. Lokhorst, A. Kate Sasser, Tuna Mutis, Niels W.C.J. van de Donk
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24): 7498–7511.
https://doi.org/10.1158/1078-0432.CCR-17-2027
Published: 14 December 2017
View article titled, Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Open the PDF for Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab in another window
Includes: Supplementary data
Journal Articles

Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease

Matthew J. Pianko, Evangelos Terpos, G. David Roodman, Chaitanya R. Divgi, Sonja Zweegman, Jens Hillengass, Suzanne Lentzsch
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 5888–5897.
https://doi.org/10.1158/1078-0432.CCR-14-1692
Published: 30 November 2014
View article titled, Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease
Open the PDF for Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease in another window
Journal Articles

High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival

Anna van Rhenen, Nicole Feller, Angèle Kelder, August H. Westra, Elwin Rombouts, Sonja Zweegman, Marjolein A. van der Pol, Quinten Waisfisz, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6520–6527.
https://doi.org/10.1158/1078-0432.CCR-05-0468
Published: 15 September 2005
View article titled, High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival
Open the PDF for High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival in another window